GlaxoSmithKline PLC

XHAM:GS7

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is GS7's stock price target?

Price Target

17.051 EUR

According to Wall Street analysts, the average 1-year price target for GS7 is 17.051 EUR with a low forecast of 11.712 EUR and a high forecast of 23.012 EUR.

What is the Revenue forecast for GlaxoSmithKline PLC?

Projected CAGR

3%

Over the last 13 years, the compound annual growth rate for Revenue has been 2%. The projected CAGR for the next 8 years is 3%.

What is the Gross Profit forecast for GlaxoSmithKline PLC?

Projected CAGR

3%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 2%. The projected CAGR for the next 8 years is 3%.

What is the Operating Income forecast for GlaxoSmithKline PLC?

Projected CAGR

4%

Over the last 13 years, the compound annual growth rate for Operating Income has been 2%. The projected CAGR for the next 8 years is 4%.

What is the Pre-Tax Income forecast for GlaxoSmithKline PLC?

Projected CAGR

14%

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 1%. The projected CAGR for the next 3 years is 14%.

What is the Net Income forecast for GlaxoSmithKline PLC?

Projected CAGR

6%

Over the last 13 years, the compound annual growth rate for Net Income has been 2%. The projected CAGR for the next 8 years is 6%.